---
title: Integrating a microRNA signature as a liquid biopsy-based tool for the early
  diagnosis and prediction of potential therapeutic targets in pancreatic cancer
date: '2023-11-10'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37950093/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231111170804&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: A panel of three miRNAs was developed with satisfactory
  statistical and computational performance in real-world data. Circulating hsa-miRNA
  205-5p serum levels serve as a minimally invasive, early detection tool for pancreatic
  cancer diagnosis and disease staging and might help monitor therapy ...'
disable_comments: true
---
CONCLUSION: A panel of three miRNAs was developed with satisfactory statistical and computational performance in real-world data. Circulating hsa-miRNA 205-5p serum levels serve as a minimally invasive, early detection tool for pancreatic cancer diagnosis and disease staging and might help monitor therapy ...